Vestal Point Capital as of Dec. 31, 2025
Portfolio Holdings for Vestal Point Capital
Vestal Point Capital holds 76 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abivax SA Sponsored Ads (ABVX) | 8.7 | $256M | 1.9M | 134.85 | |
| Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ) | 7.3 | $215M | 350k | 614.31 | |
| Arcellx Common Stock (ACLX) | 6.5 | $191M | 2.9M | 65.20 | |
| Terns Pharmaceuticals (TERN) | 6.2 | $182M | 4.5M | 40.40 | |
| BioMarin Pharmaceutical (BMRN) | 6.1 | $178M | 3.0M | 59.43 | |
| Globus Medical Cl A (GMED) | 3.8 | $111M | 1.3M | 87.31 | |
| Nurix Therapeutics (NRIX) | 3.0 | $89M | 4.7M | 18.97 | |
| Alcon Ord Shs (ALC) | 3.0 | $87M | 1.1M | 78.81 | |
| Dex (DXCM) | 2.9 | $85M | 1.3M | 66.37 | |
| Merck & Co (MRK) | 2.8 | $82M | 775k | 105.26 | |
| Taysha Gene Therapies Com Shs (TSHA) | 2.6 | $76M | 14M | 5.50 | |
| Abbott Laboratories (ABT) | 2.6 | $75M | 600k | 125.29 | |
| Immatics NV SHS (IMTX) | 2.2 | $64M | 6.1M | 10.50 | |
| Tyra Biosciences (TYRA) | 2.2 | $64M | 2.4M | 26.29 | |
| Bicara Therapeutics (BCAX) | 2.0 | $60M | 3.6M | 16.83 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.0 | $60M | 900k | 66.39 | |
| Enliven Therapeutics (ELVN) | 2.0 | $59M | 3.8M | 15.40 | |
| Disc Medicine (IRON) | 2.0 | $58M | 735k | 79.41 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.7 | $49M | 290k | 170.00 | |
| Day One Biopharmaceuticals I (DAWN) | 1.6 | $49M | 5.2M | 9.32 | |
| Lexeo Therapeutics (LXEO) | 1.5 | $44M | 4.5M | 9.93 | |
| Alto Neuroscience Com Shs (ANRO) | 1.5 | $44M | 2.5M | 17.80 | |
| Apogee Therapeutics (APGE) | 1.4 | $42M | 550k | 75.48 | |
| Olema Pharmaceuticals (OLMA) | 1.4 | $41M | 1.7M | 25.00 | |
| Axsome Therapeutics (AXSM) | 1.3 | $38M | 210k | 182.64 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 1.3 | $37M | 175k | 213.24 | |
| Rapport Therapeutics (RAPP) | 1.1 | $34M | 1.1M | 30.34 | |
| Solid Biosciences Com New (SLDB) | 1.1 | $33M | 5.8M | 5.64 | |
| Celldex Therapeutics Com New (CLDX) | 1.1 | $32M | 1.2M | 27.16 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $31M | 700k | 44.05 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $31M | 1.9M | 16.15 | |
| Vera Therapeutics Cl A (VERA) | 0.9 | $28M | 550k | 50.64 | |
| Xenon Pharmaceuticals (XENE) | 0.9 | $27M | 600k | 44.82 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.8 | $24M | 360k | 66.55 | |
| Revolution Medicines (RVMD) | 0.8 | $24M | 295k | 79.65 | |
| Zymeworks Del (ZYME) | 0.8 | $23M | 865k | 26.33 | |
| Immunocore Holdings Ads (IMCR) | 0.7 | $20M | 585k | 34.71 | |
| Upstream Bio (UPB) | 0.7 | $20M | 720k | 27.15 | |
| Beta Bionics (BBNX) | 0.6 | $18M | 600k | 30.47 | |
| Crescent Biopharma (CBIO) | 0.6 | $18M | 1.5M | 11.86 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $18M | 2.3M | 7.80 | |
| Penumbra (PEN) | 0.5 | $16M | 50k | 310.91 | |
| Geron Corporation (GERN) | 0.5 | $15M | 11M | 1.32 | |
| Repligen Corporation (RGEN) | 0.5 | $14M | 83k | 163.86 | |
| Zimmer Holdings (ZBH) | 0.5 | $14M | 150k | 89.92 | |
| Bristol Myers Squibb (BMY) | 0.5 | $14M | 250k | 53.94 | |
| Monte Rosa Therapeutics (GLUE) | 0.4 | $12M | 775k | 15.68 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $11M | 950k | 11.31 | |
| Savara (SVRA) | 0.3 | $9.7M | 1.6M | 6.03 | |
| Engene Holdings (ENGN) | 0.3 | $9.5M | 1.1M | 9.03 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $8.8M | 325k | 27.22 | |
| Definium Therapeutics Com New (MNMD) | 0.3 | $8.5M | 637k | 13.39 | |
| Denali Therapeutics (DNLI) | 0.3 | $7.7M | 465k | 16.51 | |
| Myriad Genetics (MYGN) | 0.3 | $7.5M | 1.2M | 6.15 | |
| Tectonic Therapeutic (TECX) | 0.2 | $6.8M | 328k | 20.86 | |
| Novocure Ord Shs (NVCR) | 0.2 | $6.8M | 525k | 12.93 | |
| Maplight Therapeutics (MPLT) | 0.2 | $6.8M | 385k | 17.57 | |
| Gilead Sciences (GILD) | 0.2 | $6.1M | 50k | 122.74 | |
| Voyager Therapeutics (VYGR) | 0.2 | $5.8M | 1.5M | 3.93 | |
| DBV Technologies SA Sponsored Ads (DBVT) | 0.2 | $5.8M | 300k | 19.17 | |
| Mirum Pharmaceuticals (MIRM) | 0.2 | $5.2M | 66k | 78.99 | |
| Nyxoah SA SHS (NYXH) | 0.2 | $5.1M | 1.1M | 4.60 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $4.6M | 46k | 100.59 | |
| Lenz Therapeutics (LENZ) | 0.1 | $4.4M | 275k | 16.00 | |
| Rezolute Com New (RZLT) | 0.1 | $4.0M | 1.7M | 2.36 | |
| Passage Bio Com New (PASG) | 0.1 | $3.6M | 305k | 11.80 | |
| Sutro Biopharma Com Shs (STRO) | 0.1 | $2.8M | 243k | 11.57 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $2.4M | 35k | 69.55 | |
| Dyne Therapeutics (DYN) | 0.1 | $2.3M | 120k | 19.56 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.1M | 870k | 2.43 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.1 | $1.8M | 635k | 2.90 | |
| Fate Therapeutics (FATE) | 0.1 | $1.7M | 1.7M | 0.98 | |
| Alector (ALEC) | 0.0 | $1.2M | 755k | 1.56 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $651k | 53k | 12.19 | |
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $490k | 34k | 14.40 | |
| Macrogenics (MGNX) | 0.0 | $451k | 280k | 1.61 |